SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

Successfully completed Initial Public Offering (IPO) in February 2026, raising $172.5 million and listing on Nasdaq.Reported positive topline 12-month data from Phase 1/2 trial of the Bimatoprost Drug ...
IEEE

Model-Free Predictive Current Control of PMSM Using Modified Extended State Observer

Abstract: This article proposes a modified model-free predictive current control (M-MFPCC) integrated with a modified extended state observer (MESO). The goal is to reduce torque ripple and improving ...

Trustero AI Launches Enhanced ArcherIRM Integration Delivering Continuous Control Monitoring and Intelligent Evidence Management

New capabilities introduce industry-leading AI accuracy, automate testing, and bring agentic control testing to ArcherIRM users. PALO ALTO, Calif., March 23, 2026 /PRNewswire/ -- Trustero AI, the ...